Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2022-12-16 00:00:00 ET · period of report 2022-12-15 · accession 0001209191-22-061755 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-16 | 2022-12-15 | ORIC | Piscitelli Dominic | CFO | S - Sale+OE | $3.25 | -2,089 | 67.4K | -3% | -$6,789 |
| D | 2022-12-16 | 2022-12-15 | ORIC | Piscitelli Dominic | CFO | M - OptEx | $0.00 | +6,041 | 69.5K | +10% | $0 |
| D | 2022-12-16 | 2022-12-15 | ORIC | Piscitelli Dominic | CFO | M - OptEx | $0.00 | -6,041 | 12.1K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-15 | S | D | 2,089 | $3.25 | 67,423 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-15 | M | A | 6,041 | $0.00 | 69,512 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. (F2) Includes an aggregate of 3,471 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan.. |
| 3 | Derivative | Restricted Stock Unit | 2022-12-15 | M | D | 6,041 | $0.00 | 12,084 | D | — · — to — | 6,041 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. (F4) 1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024. |